IVP · As filed with the SEC
Inspire Veterinary Partners cash flow statement, by quarter
The statement as Inspire Veterinary Partners presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Unaudited Condensed Consolidated Statements of Cash Flows · USD
| USD | Q3 2025† 3 months ended Sep 30, 2025 | Q2 2025† 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss | (2,526,274)† | (3,034,568)† | (2,415,036) | (3,966,722)† |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation and amortization | 330,498† | 258,403† | 275,392 | 309,248† |
| Amortization of debt issuance costs | 8,969† | 5,753† | 4,455 | 0† |
| Amortization of debt discount | 386,325† | 279,854† | 261,766 | 146,214† |
| Amortization of operating right of use assets | 53,418† | 53,417† | 77,723 | 60,706† |
| Stock-based compensation | 0† | — | — | 0† |
| Issuance of class A common stock for services | 454,600† | — | — | 90,000† |
| Loss on debt modification | — | — | — | 546,356† |
| Issuance of class A common stock in connection with general release agreement | — | — | — | 0† |
| Issuance of Class A common stock and pre-funded warrants in connection with commitment shares | — | — | — | 0† |
| Gain on disposal of business | — | — | — | 0† |
| Changes in operating assets and liabilities, net of effect of acquisitions: | ||||
| Accounts receivable | 154,930† | (179,258)† | 36,299 | 74,876† |
| Due from former owners | — | — | — | 0† |
| Inventory | (20,623)† | 38,161† | 41,498 | 46,945† |
| Prepaid expenses and other current assets | 128,592† | 170,040† | 258,769 | 2,147,915† |
| Other assets | — | — | — | (28,882)† |
| Accounts payable | (175,173)† | 105,447† | (209,512) | (94,079)† |
| Accrued expenses | (43,424)† | 370,053† | 357,541 | (19,348)† |
| Cumulative Series A preferred stock dividends payable | — | — | — | 0† |
| Refundable income tax | — | — | — | 0† |
| Operating lease liabilities | (40,303)† | (39,371)† | (63,192) | (47,420)† |
| Net cash used in operating activities | (1,282,695)† | (898,284)† | (1,374,297) | (677,527)† |
| Cash flows from investing activities: | ||||
| Purchase of property and equipment | (43,461)† | (12,579)† | (20,275) | (31,828)† |
| Net cash used in investing activities | (43,461)† | (1,862,579)† | (20,275) | (31,828)† |
| Cash flows from financing activities: | ||||
| Proceeds from issuance of class A common stock and warrants, net of issuance costs | 0† | 140,000† | 2,145,521 | (3,375,458)† |
| Proceeds from issuance of class A common stock and pre-funded warrants, net of issuance costs | 0† | (140,000)† | 1,711,466 | (3,608,419)† |
| Net proceeds from loans payable | 0† | — | — | 513,650† |
| Repayments on loans payable | (942,000)† | (968,460)† | (863,940) | (1,197,943)† |
| Proceeds from issuance of convertible series A preferred stock | — | — | — | 0† |
| Proceeds from convertible notes payable | 0† | — | — | — |
| Proceeds from notes payable, net of discount | 0† | — | — | 0† |
| Payments on convertible note payable | — | — | — | (44,118)† |
| Repayment of notes payable | (271,703)† | (266,753)† | (464,132) | (421,324)† |
| Proceeds from exercise of warrants | — | — | — | 500,000† |
| Proceeds from issuance of promissory note | 500,000† | — | — | — |
| Repayment of convertible debentures | — | — | — | 0† |
| Net cash provided by financing activities | 1,508,960† | 1,296,272† | 2,528,915 | 551,846† |
| Net increase (decrease) in Cash, cash equivalents and restricted cash | 182,804† | (1,464,591)† | 1,134,343 | (157,509)† |
| Cash, cash equivalents and restricted cash, beginning of period | 393,442 | 1,858,033 | 723,690 | 881,199 |
| Cash, cash equivalents and restricted cash, end of period | 576,246 | 393,442 | 1,858,033 | 723,690 |
| Supplemental Disclosure of Cash Flow Information | ||||
| Interest payments during the year | 559,111† | (725,533)† | 1,552,313 | 0† |
| Income tax refund | — | — | 151,796 | 0† |
| Noncash investing and financing activity | ||||
| Series A Preferred Stock Dividend | — | — | — | 0† |
| Issuance of common stock in connection with business acquisition | 0† | — | — | — |
| Issuance of class A common stock for conversion of convertible notes payable | — | — | — | 707,143† |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.